Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
Optimizing the downstream process for adeno-associated virus (AAV) production with consistent quality depends on the ability to characterize critical quality attributes affecting the final product’s ...
With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...
Acquisition expands Siemens' offering in PCB design for the SMB market and enables greater process coverage, from design to manufacturing preparation PLANO, Texas, April 8, 2025 /PRNewswire/ -- ...
SANTA CLARA, Calif., Feb. 20, 2018 /CNW/ -- Based on its recent analysis of the biologics downstream processing technologies industry, Frost & Sullivan recognizes 3M with the 2017 Global Product ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, ...
Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...
TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce it is investigating the construction of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback